Collectively, N6AMT1-mediated 6mA modification inhibits stomach and liver tumorigenesis and metastasis, while ALKBH1 maintains glioblastoma tumor cell viability and stemness properties via 6mA demethylation. The gene discussed is ALKBH1; the disease is neoplasm.